ERBB2 and breast carcinoma: By further considering ERBB2 status and smaller age groups, we found differing trends in hormone receptor–positive and hormone receptor–negative breast cancers based on positive ERBB2 expression, enabling us to identify additional racial/ethnic and age group variation in trends.